Alkem tamsulosin hydrochloride?

What is Alkem’s tamsulosin and who sells it?
Alkem Therapeutics Ltd. markets a generic tamsulosin hydrochloride tablet used to relieve symptoms of benign prostatic hyperplasia (BPH). The product is sold under the brand name Tamsulo in several Indian markets. The generic is a 0.4 mg capsule, the standard dose for most patients. [1]

How does tamsulosin help with BPH?
Tamsulosin is an alpha‑1A adrenergic receptor antagonist. It relaxes smooth muscle in the prostate and bladder neck, making it easier to urinate. The drug is taken once daily, usually at bedtime, to maximize effect during the night when bladder activity is lowest. [1]

What are the common side‑effect concerns?
Patients often report dizziness or orthostatic hypotension after the first dose, especially when standing quickly. Other side effects include headache, nasal congestion, and, less frequently, retrograde ejaculation. Most adverse events are mild and transient. [1]

When does the generic patent on tamsulosin expire?
The original brand‑name patents for tamsulosin (marketed as Flomax by Pfizer) expired in 2018 in the United States. Alkem’s generic version is therefore free of U.S. exclusivity; however, Indian patents and local market exclusivities may still apply. [2]

Can biosimilars enter the market before patent expiry?
Since tamsulosin is a small‑molecule drug, there are no biosimilar equivalents—only generics. Once Indian patents expire, other manufacturers can launch generic versions. Alkem already holds one of the first generics in India, giving it a head start on the market. [2]

How does Alkem’s tamsulosin compare with other alpha‑blockers?
Compared with tamsulosin, other alpha‑blockers such as doxazosin or terazosin block both alpha‑1A and alpha‑1B receptors, producing a higher rate of systemic side effects like hypotension. Tamsulosin’s selective action leads to fewer systemic effects while still effectively reducing BPH symptoms. [1]

Who else makes generic tamsulosin in India?
Several Indian pharmaceutical firms—such as Sun Pharmaceutical, Dr. Reddy’s, and Glenmark—sell their own versions of tamsulosin. These generics compete on price and availability, with Alkem positioning itself as a cost‑effective option. [1]

What does the pricing look like in the Indian market?
Alkem’s tamsulosin is typically priced between ₹10–₹15 per 0.4 mg tablet, depending on the retailer and dosage strength. This places it well below branded prices and matches the general pricing trend for generic alpha‑blockers in India. [1]

What regulatory approvals does Alkem’s tamsulosin hold?
Alkem’s product has received approval from the Central Drugs Standard Control Organization (CDSCO) in India and is registered for sale across the country. The approval includes standard bioequivalence studies that demonstrate similarity to the reference drug. [2]

Where can I find more detailed patent and pricing information?
DrugPatentWatch.com provides up‑to‑date data on patents, generic launches, and pricing trends for tamsulosin and other drugs. [3]